Researchers from the University of Huddersfield developed a method to predict how drug-eluting polymer beads can affect the body if they are modified. The UK team published their work in the European Journal of Pharmaceutical Sciences.
Polymer beads are frequently used in cases of liver cancer, where they’re injected into a patient’s arteries to block blood flow and effectively cut off the supply of oxygen and nutrients to the tumor. The beads release an anti-cancer drug locally, which reduces the systemic side effects of the treatment.
Get the full story at our sister site, Drug Delivery Business News.
The post Lab models drug-eluting polymer beads in blood flow appeared first on MassDevice.